Some of the major companies in the hormone refractory breast cancer market are AstraZeneca, AmpliMed Corporation, Roche, Bluefish Pharmaceuticals AB, NeoCorp, Sanofi Genzyme, Neopharm, Boehringer Ingelheim GmbH.